Dublin, March 11, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/7xlxzb/ingestible_sensor) has announced the addition of the "Ingestible Sensor Market - Global Forecast to 2022" report to their offering.
The ingestible sensor market size is expected to grow from USD 198.2 Million in 2015 to USD 678.2 Million by 2022, at a CAGR of 20.2% between 2016 and 2022. The growing need for medication adherence, increasing rate of chronic diseases, and demand for real-time monitoring create a huge demand for ingestible sensors across the world.
The growing complexities in diagnosing and managing chronic diseases and other biomedical activities are creating opportunities for the ingestible sensor market. The expansion of ingestible sensors in novel medical applications such as customized drug delivery is also responsible for contributing to the overall ingestible sensor market. Patients are found to be comfortable and prefer minimally invasive techniques for diagnosis and monitoring. Moreover, ingestible sensors are more accurate than the traditional medical equipment.
Therefore, these sensors are in high demand in the medical vertical. In other verticals such as sports, astronauts, animal care, mining, fire-fighting, and military, ingestible sensors are used to signify the core body temperature changes in relation with the extreme working environment. Thus, this market has a great scope for growth in the next five years.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Ingestible Sensors Market, By Component
8 Ingestible Sensors Market, By Sensor Type
9 Ingestible Sensors Market, By Vertical
10 Geographical Analysis
11 Competitive Landscape
12 Company Profiles
Companies Mentioned:
- Capsovision Inc.
- Given Imaging Ltd
- HQ, Inc.
- MC10, Inc.
- Medimetrics Personalized Drug Delivery B.V.
- Microchips Biotech, Inc.
- Olympus Corporation
- Proteus Digital Health, Inc.
For more information visit http://www.researchandmarkets.com/research/7xlxzb/ingestible_sensor
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices, Sports Medicine , Capacitive Sensors , Temperature and Heat Sensors


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Instagram Outage Disrupts Thousands of U.S. Users
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



